Diabetes Information [Return To Home Page]

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

XOMA 052 Clinical Results Support New Type 2 Diabetes Therapeutic ...
MarketWatch - 4 hours ago
XOMA 052 addresses inflammation as an underlying cause of diabetes by targeting Interleukin-1 beta (IL-1 beta), a master signaling protein which triggers ...
Xoma says antibody lowers blood sugar in diabetics Reuters
Xoma’s Phase I biologic reduces glucose levels Pharma Times (subscription)
XOMA announces interim data from two Phase 1 clinical studies of ... RTT News
all 11 news articles


Biodel's diabetes drug VIAject meets goals
Reuters - 1 hour ago
O: Quote, Profile, Research, Stock Buzz) diabetes drug VIAject is as effective as Eli Lilly and Co's (LLY.N: Quote, Profile, Research, Stock Buzz) Humulin ...


Pre-diabetes screening tests
Los Angeles Times, CA - 6 hours ago
The American Diabetes Assn. recommends that all men and women 45 and older (particularly those who are overweight) be screened every three years for ...
Painless Diabetes Test ABC30.com
all 2 news articles


Bristol, Astra diabetes pill promising in studies
Reuters - 2 hours ago
L: Quote, Profile, Research, Stock Buzz) experimental diabetes drug Onglyza significantly improves blood sugar control when added to older medicines, ...
UPDATE: AstraZeneca Onglyza Effective, Tolerated In Studies CNNMoney.com
all 6 news articles


Oneindia

Reliable Test To Spot Pre-Diabetes Developed
Oneindia, India - 7 hours ago
Lead researcher Gerald Hart says that early stages of the disease, scientifically known as "pre-diabetes", are characterised by increased reaction rates ...


TheMedGuru

Once-Weekly Diabetes Drug Boosts Blood Sugar Control
Washington Post, United States - 10 hours ago
7 (HealthDay News) -- A new once-a-week formulation of the injectable diabetes drug Byetta controls blood sugar even better than the older twice-a-day ...
Weekly jab offers hope for diabetes sufferers Telegraph.co.uk
New weekly treatment for type 2 diabetes works better than twice ... guardian.co.uk
Good News for People with Type 2 Diabetes: New Once-Weekly Jab TheMedGuru
News-Medical.net - Food Consumer
all 36 news articles


BBC News

Weekly diabetes jab hopes raised
BBC News, UK - 3 hours ago
It may be possible to replace twice a day jabs to control type 2 diabetes with a shot given just once a week, research suggests. ...
Weekly diabetes drug provides better blood sugar control, spurs ... The Canadian Press
Constant Blood-Sugar Monitoring Helps Adults Only in Study Bloomberg
New Study Demonstrates Glucose Device Rapidly Alleviates Major ... Newswise (press release)
all 13 news articles


Business to raise funds to combat juvenile diabetes
Lancaster Eagle Gazette, OH - 1 hour ago
By JEFFREY BARRON LANCASTER - Advance Auto Parts store manager Troy Jackson is planning a fun way to fight the serious issue of juvenile diabetes. ...


More than 4000 walk for diabetes cure
Peoria Journal Star, IL - 9 hours ago
Andriella was diganosed with juvenile diabetes last May, and the family formed a group called "Andri's Army" to support her among hundreds of other families ...
Walking for Juvenile Diabetes WEEK-TV
Walking for a Cure Central Illinois Proud
all 4 news articles


Diabetes course offered in October
Marshall News Messenger, TX - 10 hours ago
By Louraisel McDonald The number of people with diabetes has increased by three million in three years to a new high of 24 million, according to the Center ...
Education association members are headed to state competition Marshall News Messenger
Sign up for programs from wildlife to pesticide training Marshall News Messenger
all 3 news articles

Diabetes - Google News






home | site map
© 2006